# FDA Inspection 1153214 - Hiossen Inc. - August 20, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/hiossen-inc/f7d42e37-89be-45d1-a566-a7417ebe217b/
Source feed: FDA_Inspections

> FDA Inspection 1153214 for Hiossen Inc. on August 20, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1153214
- Company Name: Hiossen Inc.
- Inspection Date: 2021-08-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1044565 - 2018-02-20](https://www.globalkeysolutions.net/api/records/fda_inspections/hiossen-inc/81c50667-afc8-4b7b-a4f9-9de0662f9324/)
- [FDA Inspection 1038513 - 2017-04-24](https://www.globalkeysolutions.net/api/records/fda_inspections/hiossen-inc/6c2920e7-6c58-4424-9703-46b4cfcbb7a7/)
- [FDA Inspection 963504 - 2016-03-23](https://www.globalkeysolutions.net/api/records/fda_inspections/hiossen-inc/83b4ef43-b6b7-4ad0-b715-43cbcb6e0cf4/)

Company: https://www.globalkeysolutions.net/companies/hiossen-inc/5913cd53-b64c-4d14-a379-c5812e63a60d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d